Skip to content
Snippets Groups Projects
Commit 250b4ae3 authored by Jianghuan Xu's avatar Jianghuan Xu :speech_balloon:
Browse files

Update 15.results.md

parent aa32c2e9
No related branches found
No related tags found
No related merge requests found
Pipeline #348884 passed
...@@ -35,6 +35,7 @@ HIPs are regulated by the Fumarate and Nitrate Reduction regulator (FNR)[$^1$]. ...@@ -35,6 +35,7 @@ HIPs are regulated by the Fumarate and Nitrate Reduction regulator (FNR)[$^1$].
Thus, on the base of wild type PepT promoter, we strived to change the intensity of its expression by mutating TATA box, mutating FNR box, and changing the RBS. We use the PJUMP41-2A (sfGFP) plasmid (BBa_J428365, this plasmid referred below are abbreviated as O12, as it corresponds to the O12 well on the biobrick) as our vector This plasmid is characterized as a low-copy plasmid with spectinomycin resistance and carries the BBa_J23100 promoter along with the sfGFP sequence. Through reverse PCR and gibson assembly (details are shown in “Engineering”), we successfully replaced the J23100 promoter and RBS with the following 10 promoters + RBS (see **BBa_K4713116 - BBa_K4713125**): Thus, on the base of wild type PepT promoter, we strived to change the intensity of its expression by mutating TATA box, mutating FNR box, and changing the RBS. We use the PJUMP41-2A (sfGFP) plasmid (BBa_J428365, this plasmid referred below are abbreviated as O12, as it corresponds to the O12 well on the biobrick) as our vector This plasmid is characterized as a low-copy plasmid with spectinomycin resistance and carries the BBa_J23100 promoter along with the sfGFP sequence. Through reverse PCR and gibson assembly (details are shown in “Engineering”), we successfully replaced the J23100 promoter and RBS with the following 10 promoters + RBS (see **BBa_K4713116 - BBa_K4713125**):
<br> <br>
**Table 1 | The promoter + RBS sequences used in screening.** **Table 1 | The promoter + RBS sequences used in screening.**
<center><img src="r2/table.jpg" alt="Table 1" style="width: 100%;" /></center> <center><img src="r2/table.jpg" alt="Table 1" style="width: 100%;" /></center>
...@@ -363,4 +364,4 @@ This design can be utilized to optimize therapeutic bacteria administration to m ...@@ -363,4 +364,4 @@ This design can be utilized to optimize therapeutic bacteria administration to m
9. Bourdeau, R. W. *et al.* Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts. *Nature* **553**, 86–90 (2018). 9. Bourdeau, R. W. *et al.* Acoustic reporter genes for noninvasive imaging of microorganisms in mammalian hosts. *Nature* **553**, 86–90 (2018).
10. Solé, R. & Conde-Pueyo, N. Ultrasound approach tracks gut microbes. *Nature* **553**, 36–37 (2018). 10. Solé, R. & Conde-Pueyo, N. Ultrasound approach tracks gut microbes. *Nature* **553**, 36–37 (2018).
11. Harimoto, T. *et al.* A programmable encapsulation system improves delivery of therapeutic bacteria in mice. *Nat Biotechnol* **40**, 1259–1269 (2022). 11. Harimoto, T. *et al.* A programmable encapsulation system improves delivery of therapeutic bacteria in mice. *Nat Biotechnol* **40**, 1259–1269 (2022).
12. Fu, X. & Xu, J.-G. Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker. *Microbiology and immunology* **44**, 551–556 (2000). 12. Fu, X. & Xu, J.-G. Development of a chromosome-plasmid balanced lethal system for Lactobacillus acidophilus with thyA gene as selective marker. *Microbiology and immunology* **44**, 551–556 (2000).
\ No newline at end of file
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment